» Articles » PMID: 33211680

COVID-19 Outbreak - New York City, February 29-June 1, 2020

Abstract

New York City (NYC) was an epicenter of the coronavirus disease 2019 (COVID-19) outbreak in the United States during spring 2020 (1). During March-May 2020, approximately 203,000 laboratory-confirmed COVID-19 cases were reported to the NYC Department of Health and Mental Hygiene (DOHMH). To obtain more complete data, DOHMH used supplementary information sources and relied on direct data importation and matching of patient identifiers for data on hospitalization status, the occurrence of death, race/ethnicity, and presence of underlying medical conditions. The highest rates of cases, hospitalizations, and deaths were concentrated in communities of color, high-poverty areas, and among persons aged ≥75 years or with underlying conditions. The crude fatality rate was 9.2% overall and 32.1% among hospitalized patients. Using these data to prevent additional infections among NYC residents during subsequent waves of the pandemic, particularly among those at highest risk for hospitalization and death, is critical. Mitigating COVID-19 transmission among vulnerable groups at high risk for hospitalization and death is an urgent priority. Similar to NYC, other jurisdictions might find the use of supplementary information sources valuable in their efforts to prevent COVID-19 infections.

Citing Articles

Influence of Psychological Safety and Safety Climate Perceptions on Nurses' Infection Prevention and Occupational Safety Practices and Environment.

Thurman Johnson C, Owen N, Hessels A Nurs Rep. 2025; 15(2).

PMID: 39997773 PMC: 11858599. DOI: 10.3390/nursrep15020037.


Practical application of good participatory practices for trials of emerging pathogens: Developing materials for use in ACTIV-3, -3b, and ACTIV-associated COVID-19 trials.

Guerra-de-Blas P, Marines-Price R, Milman O, Deal D, Marchand J, Linton J J Clin Transl Sci. 2024; 8(1):e157.

PMID: 39610837 PMC: 11602519. DOI: 10.1017/cts.2024.485.


Impact of neighborhood-level COVID-19 mortality on the increase in drug overdose mortality in New York City during the COVID-19 pandemic.

Olawole W, Li G, Zhou Z, Wu Z, Chen Q Inj Epidemiol. 2024; 11(1):65.

PMID: 39578923 PMC: 11585137. DOI: 10.1186/s40621-024-00548-8.


Sentiment Analysis of Twitter Posts Related to a COVID-19 Test & Trace Program in NYC.

Tsai K, Chau M, Wang J, Thorpe L, Massar R, Conderino S J Urban Health. 2024; 101(5):898-901.

PMID: 39325247 PMC: 11461426. DOI: 10.1007/s11524-024-00906-3.


Barriers and Facilitators to Trust in the COVID-19 New York City Test and Trace Program.

Chau M, Larson R, Paul M, Massar R, Kwok L, Berry C J Urban Health. 2024; 101(5):879-887.

PMID: 39285149 PMC: 11461413. DOI: 10.1007/s11524-024-00911-6.


References
1.
. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):465-471. PMC: 7755058. DOI: 10.15585/mmwr.mm6915e4. View

2.
Gonzalez-Reiche A, Hernandez M, Sullivan M, Ciferri B, Alshammary H, Obla A . Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020; 369(6501):297-301. PMC: 7259823. DOI: 10.1126/science.abc1917. View

3.
Bailey Z, Krieger N, Agenor M, Graves J, Linos N, Bassett M . Structural racism and health inequities in the USA: evidence and interventions. Lancet. 2017; 389(10077):1453-1463. DOI: 10.1016/S0140-6736(17)30569-X. View

4.
Van Dorn A, Cooney R, Sabin M . COVID-19 exacerbating inequalities in the US. Lancet. 2020; 395(10232):1243-1244. PMC: 7162639. DOI: 10.1016/S0140-6736(20)30893-X. View

5.
Bushman D, Alroy K, Greene S, Keating P, Wahnich A, Weiss D . Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(28):918-922. PMC: 7366849. DOI: 10.15585/mmwr.mm6928a5. View